NVLT is on Track to Advance I-131-CLR1404 (HOT) By Grant Zeng, CFA On September 11, 2012, Novelos Therapeutics, Inc. ( NVLT ) successfully completed the second cohort in a U.S.
View article:
Novelos Is Advancing Three Candidates Based On Its Unique Diapeutic Platform – Analyst Blog